SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elvira Verduci, Carlotta Lassandro, Giovanni Radaelli, Laura Soldati, Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?, Journal of Translational Medicine, 2015, 13, 1

    CrossRef

  2. 2
    Srinivasan Dasarathy, Jaividhya Dasarathy, Amer Khiyami, Lisa Yerian, Carol Hawkins, Ruth Sargent, Arthur J. McCullough, Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis, Journal of Clinical Gastroenterology, 2015, 49, 2, 137

    CrossRef

  3. 3
    Curtis K. Argo, James T. Patrie, Carolin Lackner, Thomas D. Henry, Eduard E. de Lange, Arthur L. Weltman, Neeral L. Shah, Abdullah M. Al-Osaimi, Patcharin Pramoonjago, Saumya Jayakumar, Lukas P. Binder, Winsor D. Simmons-Egolf, Sandra G. Burks, Yongde Bao, Ann Gill Taylor, Jessica Rodriguez, Stephen H. Caldwell, Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial, Journal of Hepatology, 2015, 62, 1, 190

    CrossRef

  4. 4
    T. O. Freire, R. S. S. B. Boulhosa, L. P. M. Oliveira, R. P. Jesus, L. N. Cavalcante, D. C. Lemaire, M. B. P. Toralles, L. G. C. Lyra, A. C. Lyra, n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial, Journal of Human Nutrition and Dietetics, 2015, 28, 4
  5. 5
    Claudia Filozof, Barry J. Goldstein, Richard N. Williams, Arun Sanyal, Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway, Drugs, 2015,

    CrossRef

  6. 6
    Monize Aydar Nogueira, Claudia Pinto Oliveira, Venâncio Avancini Ferreira Alves, José Tadeu Stefano, Lívia Samara dos Reis Rodrigues, Raquel Susana Torrinhas, Bruno Cogliati, Hermes Barbeiro, Flair José Carrilho, Dan Linetzky Waitzberg, Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial, Clinical Nutrition, 2015,

    CrossRef

  7. 7
    S. A. AlKhater, Paediatric non-alcoholic fatty liver disease: an overview, Obesity Reviews, 2015, 16, 5
  8. 8
    Cristina López-Vicario, Bibiana Rius, José Alcaraz-Quiles, Verónica García-Alonso, Aritz Lopategi, Esther Titos, Joan Clària, Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases, European Journal of Pharmacology, 2015,

    CrossRef

  9. 9
    Min-Hsiung Pan, Ching-Shu Lai, Mei-Ling Tsai, Chi-Tang Ho, Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds, Molecular Nutrition & Food Research, 2014, 58, 1
  10. 10
    Claudia Della Corte, Daniela Liccardo, Federica Ferrari, Anna Alisi, Valerio Nobili, Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease, Expert Opinion on Pharmacotherapy, 2014, 15, 17, 2501

    CrossRef

  11. 11
    Anja Fink, Corinna E. Rüfer, Julie Le Grandois, Alexander Roth, Dalal Aoude-Werner, Eric Marchioni, Achim Bub, Stephan W. Barth, Dietary walnut oil modulates liver steatosis in the obese Zucker rat, European Journal of Nutrition, 2014, 53, 2, 645

    CrossRef

  12. 12
    Mohamed Asrih, François R. Jornayvaz, Diets and nonalcoholic fatty liver disease: The good and the bad, Clinical Nutrition, 2014, 33, 2, 186

    CrossRef

  13. 13
    Mingming Yu, Yuanhong Wang, Tingfu Jiang, Zhihua Lv, Effects of sulfate chitosan derivatives on nonalcoholic fatty liver disease, Journal of Ocean University of China, 2014, 13, 3, 531

    CrossRef

  14. 14
    Po Sing Leung, Fatty acid receptor GPR120: its potential role in islet function and Type 2 diabetes mellitus, Diabetes Management, 2014, 4, 3, 223

    CrossRef

  15. 15
    Naoki Kabeya, Yutaka Takeuchi, Yoji Yamamoto, Ryosuke Yazawa, Yutaka Haga, Shuichi Satoh, Goro Yoshizaki, Modification of the n-3 HUFA biosynthetic pathway by transgenesis in a marine teleost, nibe croaker, Journal of Biotechnology, 2014, 172, 46

    CrossRef

  16. 16
    AiXuan Holterman, Juan Gurria, Smita Tanpure, Nerina DiSomma, Nonalcoholic fatty liver disease and bariatric surgery in adolescents, Seminars in Pediatric Surgery, 2014, 23, 1, 49

    CrossRef

  17. 17
    S. Berardis, E. Sokal, Pediatric non-alcoholic fatty liver disease: an increasing public health issue, European Journal of Pediatrics, 2014, 173, 2, 131

    CrossRef

  18. 18
    Amirhossein Sahebkar, Gerard T. Chew, Gerald F. Watts, Recent advances in pharmacotherapy for hypertriglyceridemia, Progress in Lipid Research, 2014, 56, 47

    CrossRef

  19. 19
    Simón Perera, Laura Artigas, Roger Mulet, José M. Mas, Teresa Sardón, Systems biology applied to non-alcoholic fatty liver disease (NAFLD): treatment selection based on the mechanism of action of nutraceuticals, Nutrafoods, 2014, 13, 2, 61

    CrossRef

  20. 20
    Manfredi Rizzo, Giuseppe Montalto, Khalid Al-Rasadi, Treatment options for managing atherogenic dyslipidemia and fatty liver disease, Expert Opinion on Pharmacotherapy, 2014, 15, 8, 1065

    CrossRef

  21. 21
    Valerio Nobili, Gianluca Svegliati-Baroni, Anna Alisi, Luca Miele, Luca Valenti, Pietro Vajro, A 360-degree overview of paediatric NAFLD: Recent insights, Journal of Hepatology, 2013, 58, 6, 1218

    CrossRef

  22. 22
    Zhen-Yu Du, Tao Ma, Bjørn Liaset, Alison H. Keenan, Pedro Araujo, Erik-Jan Lock, Laurent Demizieux, Pascal Degrace, Livar Frøyland, Karsten Kristiansen, Lise Madsen, Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013, 1831, 2, 291

    CrossRef

  23. 23
    V. Nobili, A. Alisi, C. Della Corte, P. Risé, C. Galli, C. Agostoni, G. Bedogni, Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children, Nutrition, Metabolism and Cardiovascular Diseases, 2013, 23, 11, 1066

    CrossRef

  24. 24
    David E. St-Jules, Corilee A. Watters, Elizabeth M. Brunt, Lynne R. Wilkens, Rachel Novotny, Patricia Belt, Joel E. Lavine, Estimation of Fish and ω-3 Fatty Acid Intake in Pediatric Nonalcoholic Fatty Liver Disease, Journal of Pediatric Gastroenterology and Nutrition, 2013, 57, 5, 627

    CrossRef

  25. 25
    Antonin Lamaziere, Claude Wolf, Ullah Barbe, Pedro Bausero, Francesco Visioli, Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2013, 88, 2, 149

    CrossRef

  26. 26
    Anne-Mari Mustonen, Vesa Kärjä, Michael Kilpiö, Raija Tammi, Markku Tammi, Kirsti Rouvinen-Watt, Toivo Halonen, Petteri Nieminen, Manifestations of Fasting-Induced Fatty Liver and Rapid Recovery from Steatosis in Voles Fed Lard or Flaxseed Oil Lipids, Nutrients, 2013, 5, 10, 4211

    CrossRef

  27. 27
    C. Lopez-Vicario, A. Gonzalez-Periz, B. Rius, E. Moran-Salvador, V. Garcia-Alonso, J. J. Lozano, R. Bataller, M. Cofan, J. X. Kang, V. Arroyo, J. Claria, E. Titos, Molecular interplay between  5/ 6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis, Gut, 2013,

    CrossRef

  28. 28
    Ryan M. Gill, Sanjay Kakar, Nonalcoholic Steatohepatitis, Surgical Pathology Clinics, 2013, 6, 2, 227

    CrossRef

  29. 29
    Jill R. Cherry-Bukowiec, Optimizing Nutrition Therapy to Enhance Mobility in Critically Ill Patients, Critical Care Nursing Quarterly, 2013, 36, 1, 28

    CrossRef

  30. 30
    Nicola Santoro, Sonia Caprio, Ariel E Feldstein, Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis, Clinical Lipidology, 2013, 8, 4, 411

    CrossRef

  31. 31
    Valentina Giorgio, Federica Prono, Francesca Graziano, Valerio Nobili, Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets, BMC Pediatrics, 2013, 13, 1, 40

    CrossRef

  32. 32
    Maeva Guillaume, Vlad Ratziu, Pharmacological agents for nonalcoholic steatohepatitis, Hepatology International, 2013, 7, S2, 833

    CrossRef

  33. 33
    Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios, Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids, Nutrition Reviews, 2013, 71, 11
  34. 34
    C. Ferreri, Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease, 2013,

    CrossRef

  35. 35
    Neal D. Freedman, Jorge A. Marrero, Can Dietary Fish Intake Prevent Liver Cancer?, Gastroenterology, 2012, 142, 7, 1411

    CrossRef

  36. 36
    Dawn M. Fedor, Yuriko Adkins, Bruce E. Mackey, Darshan S. Kelley, Docosahexaenoic Acid PreventsTrans-10,Cis-12–Conjugated Linoleic Acid-Induced Nonalcoholic Fatty Liver Disease in Mice by Altering Expression of Hepatic Genes Regulating Fatty Acid Synthesis and Oxidation, Metabolic Syndrome and Related Disorders, 2012, 10, 3, 175

    CrossRef

  37. 37
    Jochem R. van Werven, Hendrik A. Marsman, Aart J. Nederveen, Fiebo J. ten Kate, Thomas M. van Gulik, Jaap Stoker, Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model, Magnetic Resonance Imaging, 2012, 30, 1, 112

    CrossRef

  38. 38
    Anna Alisi, Valerio Nobili, Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments, Nutrition, 2012, 28, 7-8, 722

    CrossRef

  39. 39
    L. S. Bhatia, N. P. Curzen, P. C. Calder, C. D. Byrne, Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?, European Heart Journal, 2012, 33, 10, 1190

    CrossRef

  40. 40
    Nicole J.W. de Wit, Lydia A. Afman, Marco Mensink, Michael Müller, Phenotyping the effect of diet on non-alcoholic fatty liver disease, Journal of Hepatology, 2012, 57, 6, 1370

    CrossRef

  41. 41
    Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, The American Journal of Gastroenterology, 2012, 107, 6, 811

    CrossRef

  42. 42
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 2012, 142, 7, 1592

    CrossRef

  43. You have free access to this content43
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 2012, 55, 6
  44. 44
    Yan Li, Dongfeng Chen, The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease, Journal of Hepatology, 2012, 57, 2, 468

    CrossRef

  45. 45
    V. Nobili, G. Bedogni, R. Berni Canani, P. Brambilla, S. Cianfarani, A. Pietrobelli, C. Agostoni, The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk?, Pediatric Obesity, 2012, 7, 6
  46. 46
    Pietro Vajro, Selvaggia Lenta, Claudio Pignata, Mariacarolina Salerno, Roberta D’Aniello, Ida De Micco, Giulia Paolella, Giancarlo Parenti, Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions, Italian Journal of Pediatrics, 2012, 38, 1, 55

    CrossRef

  47. 47
    W. Nseir, A. Shalata, A. Marmor, N. Assy, Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease, Digestive Diseases and Sciences, 2011, 56, 12, 3439

    CrossRef

  48. 48
    E. Matthew Morris, R. Scott Rector, John P. Thyfault, Jamal A. Ibdah, Mitochondria and Redox Signaling in Steatohepatitis, Antioxidants & Redox Signaling, 2011, 15, 2, 485

    CrossRef

  49. 49
    Yong Zhang, Longchang Jiang, Wenjun Hu, Qichang Zheng, Wenpei Xiang, Mitochondrial dysfunction during in vitro hepatocyte steatosis is reversed by omega-3 fatty acid–induced up-regulation of mitofusin 2, Metabolism, 2011, 60, 6, 767

    CrossRef

  50. 50
    E. Scorletti, P. C. Calder, C. D. Byrne, Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments, Endocrine, 2011, 40, 3, 332

    CrossRef

  51. 51
    Dariush Mozaffarian, Jason H.Y. Wu, Omega-3 Fatty Acids and Cardiovascular Disease, Journal of the American College of Cardiology, 2011, 58, 20, 2047

    CrossRef

  52. 52
    Kengo Tomita, Toshiaki Teratani, Hirokazu Yokoyama, Takahiro Suzuki, Rie Irie, Hirotoshi Ebinuma, Hidetsugu Saito, Ryota Hokari, Soichiro Miura, Toshifumi Hibi, Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences, 2011, 56, 10, 3045

    CrossRef

  53. 53
    Kazuhiko Koike, Hideyuki Miyoshi, Hiroshi Yotsuyanagi, Kyoji Moriya, Reply to the Letter to the Editor ‘Effect of treatment with polyunsatured fatty acids on HCV- or diet-induced fatty liver’, Journal of Hepatology, 2011, 54, 6, 1326

    CrossRef

  54. 54
    Anna Alisi, Carlo Agostoni, Valerio Nobili, Supplementation of Monounsaturated and Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome, Lipids, 2011, 46, 5, 389

    CrossRef

  55. 55
    Valerio Nobili, Giorgio Bedogni, Anna Alisi, Carlo Agostoni, Natural approach against lipotoxic traffic in nonalcoholic fatty liver disease, Hepatology, 2010, 52, 1
  56. 56
    Gerald F Watts, Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease, Current Opinion in Lipidology, 2010, 21, 6, 545

    CrossRef

  57. 57
    Stephen H. Caldwell, Curtis K. Argo, Abdullah M. S. Al-Osaimi, Nonalcoholic Fatty Liver Disease,
  58. 58
    Siheng Lin, Kun Xiao, Yangyang Liu, Peizhu Su, Pingyan Chen, Yali Zhang, Yang Bai, Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease, The Cochrane Library,
  59. 59
    Viviana P. Rubio, J. Paniagua-Michel, Jorge Olmos, Omegas: Pharmaceutical High Value Products and One of the Most Functional Bioactive Compounds,